Skip to main content
. 2021 Oct 15;8:711398. doi: 10.3389/fnut.2021.711398

Figure 6.

Figure 6

PPARα mediates REV-ERBα transcriptional activation. (A–C) PPARα binding to the enhancer of Nr1d1 (upper panel) and the promoter of Nr1d1 (lower panel) determined by ChIP-qPCR in the hepatocytes of vehicle control, CLA, or cotreatment of CLA with PPARα antagonists (GW6471, MK866) in (A), or cotreatment of CLA with REV-ERBα antagonists (SR8278, GSK1362) in (B), or CLA with PPARα knockdown in (C). (D) Relative enrichment of histone marks H3K27ac and H3K4me1, and Pol-II and Ser2P Pol-II recruitment at the enhancer of Nr1d1. (E) Relative enrichment of histone marks H3K27ac and H3K4me3, and Pol-II and Ser5P Pol-II recruitment at the promoter of Nr1d1. The data are shown as the means ± SD, n = 6 per group. The experiments were repeated three times. *p < 0.05, ***p < 0.001, using ANOVA with Tukey's post-hoc test.